EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE


LinkedIn facebook twitter youtube
News archive
Recent news

 

Myeloma Patients Europe (MPE) is seeking research grant applications, for funding of up to 100k €, on a project exploring shared-decision making in myeloma.

If you are interested, please read the information below and complete the following application form.  Deadline for submission is 3 pm CET on Friday 5th of November 2021

 

About the project

At MPE, we want to ensure that myeloma patients are as informed as possible when making decisions about their treatment. Evidence suggests that personal factors and preferences are influential in determining how patients arrive at treatment decisions. High quality information and support is also part of this decision making process. However, less is known about how patient information is actually used and how treatment decisions are made in practice, particularly across Eastern and Southern Europe.

This project aims to develop our understanding of information and shared decision making in myeloma. The project is about understanding, from a patient perspective, what health care professionals need to know. How do patients with myeloma and their families want to be involved in treatment decision making? What would help? What is working? Are there any examples of good practice which could be modelled and disseminated across Europe?

 

Who we are looking for

MPE have funding of up to 100k€ for a 12-month project examining shared decision making We are looking for researchers to run the project as a university partner.

MPE will support patient engagement, recruitment, and any translations needed as part of the project. A steering group made up of patients, health care professionals, and researchers will be set up to guide and support the project.

 

Further information

If you would like an informal discussion about the project, funding, or would like more details please contact Dr Jayne Galinsky, the MPE Head of Patient Evidence at galinsky@mpeurope.org.







Recent news

» Myeloma Patients Europe (MPE) relaunches Myeloma Access Atlas platform

» MPE presents its poster on the impact of COVID-19 on the treatment and care of patients with myeloma and AL amyloidosis at IMW 2021

Leave a Reply

Your email address will not be published. Required fields are marked *

I accept the Privacy Policy